A new responder criterion (relative effect per patient (REPP) >0.2) externally validated in a large total hip replacement multicenter cohort (EUROHIP)
<strong>Objective:</strong> To validate a new method to identify responders (relative effect per patient (REPP) >0.2) using the OMERACT-OARSI criteria as gold standard in a large multicentre sample. <strong>Method:</strong> The REPP ([score before – after treatment]...
Glavni autori: | , , , , , |
---|---|
Format: | Journal article |
Izdano: |
Elsevier
2015
|